Dr. Alejandra Gutierrez Bernal, MD

Dr. Gutierrez Bernal practices at Mercy Hospital in Coon Rapids, Minnesota, part of Sutter Health.

Dr. Gutierrez Bernal's NPI, 1487074597, was assigned on April 16, 2014. Dr. Gutierrez Bernal holds Minnesota license 61972.

Dr. Gutierrez Bernal's primary practice is Mercy Hospital, at 4050 Coon Rapids Blvd, Coon Rapids, MN 55433 in Anoka County. The practice phone is (762) 236-6000.

Dr. Gutierrez Bernal's primary practice is Mercy Hospital in Coon Rapids, Minnesota, part of Sutter Health. Dr. Gutierrez Bernal is also affiliated with M Health Fairview University of Minnesota Medical Center. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Gutierrez Bernal to 3 more hospitals, 9 medical groups, 3 group practices and clinics, 1 community health center and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gutierrez Bernal practices, 10 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Gutierrez Bernal's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Gutierrez Bernal's licenses on file in 2 states: Minnesota and Ohio.

CMS data shows 447 Medicare services from Dr. Gutierrez Bernal across 8 procedure codes in 2024, for 204 Medicare patients. Medicare paid $44,291 for them.

CMS counts 204 Medicare patients who saw Dr. Gutierrez Bernal in 2024. The largest group is 65 to 74, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gutierrez Bernal's median patient age at 64, with 48% women.

In 2024, Dr. Gutierrez Bernal wrote 116 Medicare Part D claims for 18 patients. 88% of them were for generic drugs. CMS names the drug for 59 of them, across 4 drugs with 11 or more claims each, at $964 in total drug cost. In 2023, CMS named 63 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Gutierrez Bernal for performance year 2024, reported as part of a group. Dr. Gutierrez Bernal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Gutierrez Bernal, published from 2023 to 2025. Dr. Gutierrez Bernal's most frequent co-authors are Tamas Alexy, MD, PhD, Jason Alan Bartos, MD and Ranjit John, MD.

CMS Open Payments shows 13 general payments to Dr. Gutierrez Bernal from 6 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 72% of the total. Medtronic Vascular, Inc. paid the most, $176.